Expert Review of Molecular Diagnostics

Carrier analysis for hemophilia A: ideal versus acceptable
pp. 203-207(5)
Author: Husain, Nuzhat

Vascular biomarkers in the metabolic syndrome
pp. 209-215(7)
Authors: Thande, Njeri; Rosenson, Robert S

Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine
pp. 217-221(5)
Author: Roukos, Dimitrios H

News in brief
pp. 223-225(3)

Personalized cancer diagnostics and therapeutics
pp. 227-229(3)
Author: Roukos, Dimitrios H

mTOR in renal cell cancer: modulator of tumor biology and therapeutic target
pp. 231-241(11)
Author: Wysocki, Piotr J

DNA methylation changes in prostate cancer: current developments and future clinical implementation
pp. 243-257(15)
Author: Hoque, Mohammad Obaidul

Epigenetic biomarkers in urothelial bladder cancer
pp. 259-269(11)
Authors: Kim, Wun-Jae; Kim, Yong-June

Blood-based transcriptomics: leukemias and beyond
pp. 271-280(10)
Authors: Staratschek-Jox, Andrea; Classen, Sabine; Gaarz, Andrea; Debey-Pascher, Svenja; Schultze, Joachim L

Recent perspectives on the genetic background of neural tube defects with special regard to iniencephaly
pp. 281-293(13)
Authors: Joó, József Gábor

Acknowledgements
pp. 297-297(1)